213 related articles for article (PubMed ID: 30887197)
21. 3.0 T prostate MRI: Visual assessment of 2D and 3D T2-weighted imaging sequences using PI-QUAL score.
Brillat-Savarin N; Wu C; Aupin L; Thoumin C; Hamzaoui D; Renard-Penna R
Eur J Radiol; 2023 Sep; 166():110974. PubMed ID: 37453273
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-Weighted Imaging of the Prostate: Image Quality and Geometric Distortion of Readout-Segmented Versus Selective-Excitation Accelerated Acquisitions.
Barth BK; Cornelius A; Nanz D; Eberli D; Donati OF
Invest Radiol; 2015 Nov; 50(11):785-91. PubMed ID: 26146870
[TBL] [Abstract][Full Text] [Related]
23. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
[TBL] [Abstract][Full Text] [Related]
24. [Effects of different computed high b-values on diffusion weighted imaging scores in Prostate Imaging Reporting and Data System version 2 of prostate cancer in peripheral zone].
Wang W; Shao ZH; Zeng JQ; Wu DL; Wang GL; Wang PJ
Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(43):3401-3405. PubMed ID: 29179281
[No Abstract] [Full Text] [Related]
25. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
26. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
27. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI.
Almansour H; Afat S; Fritz V; Schick F; Nachbar M; Thorwarth D; Zips D; Müller AC; Nikolaou K; Othman AE; Wegener D
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810410
[TBL] [Abstract][Full Text] [Related]
28. Conventional vs. reduced field of view diffusion weighted imaging of the prostate: Comparison of image quality, correlation with histology, and inter-reader agreement.
Warndahl BA; Borisch EA; Kawashima A; Riederer SJ; Froemming AT
Magn Reson Imaging; 2018 Apr; 47():67-76. PubMed ID: 29103977
[TBL] [Abstract][Full Text] [Related]
29. Comparison of synthesized and acquired high b-value diffusion-weighted MRI for detection of prostate cancer.
Kallis K; Conlin CC; Zhong AY; Hussain TS; Chatterjee A; Karczmar GS; Rakow-Penner R; Dale AM; Seibert TM
Cancer Imaging; 2024 Jul; 24(1):89. PubMed ID: 38972972
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of accelerated simultaneous multislice diffusion-weighted MRI of the prostate.
Weiss J; Martirosian P; Taron J; Othman AE; Kuestner T; Erb M; Bedke J; Bamberg F; Nikolaou K; Notohamiprodjo M
J Magn Reson Imaging; 2017 Nov; 46(5):1507-1515. PubMed ID: 28199041
[TBL] [Abstract][Full Text] [Related]
31. Comparison of single-shot EPI and multi-shot EPI in prostate DWI at 3.0 T.
Tamada T; Kido A; Ueda Y; Takeuchi M; Kanki A; Neelavalli J; Yamamoto A
Sci Rep; 2022 Sep; 12(1):16070. PubMed ID: 36168032
[TBL] [Abstract][Full Text] [Related]
32. High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T.
Wang X; Qian Y; Liu B; Cao L; Fan Y; Zhang JJ; Yu Y
Clin Radiol; 2014 Nov; 69(11):1165-70. PubMed ID: 25182363
[TBL] [Abstract][Full Text] [Related]
33. Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI.
Ueno Y; Kitajima K; Sugimura K; Kawakami F; Miyake H; Obara M; Takahashi S
J Magn Reson Imaging; 2013 Jul; 38(1):154-60. PubMed ID: 23292979
[TBL] [Abstract][Full Text] [Related]
34. T2- and diffusion-weighted magnetic resonance imaging at 3T for the detection of prostate cancer with and without endorectal coil: An intraindividual comparison of image quality and diagnostic performance.
Baur AD; Daqqaq T; Wagner M; Maxeiner A; Huppertz A; Renz D; Hamm B; Fischer T; Durmus T
Eur J Radiol; 2016 Jun; 85(6):1075-84. PubMed ID: 27161055
[TBL] [Abstract][Full Text] [Related]
35. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
36. Feasibility Study of 3-T DWI of the Prostate: Readout-Segmented Versus Single-Shot Echo-Planar Imaging.
Li L; Wang L; Deng M; Liu H; Cai J; Sah VK; Liu J
AJR Am J Roentgenol; 2015 Jul; 205(1):70-6. PubMed ID: 26102382
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
[TBL] [Abstract][Full Text] [Related]
38. Computed high-b-value high-resolution DWI improves solid lesion detection in IPMN of the pancreas.
Harder FN; Jung E; Weiss K; Graf MM; Kamal O; McTavish S; Van AT; Demir IE; Friess H; Phillip V; Schmid RM; Lohöfer FK; Kaissis GA; Makowski MR; Karampinos DC; Braren RF
Eur Radiol; 2023 Oct; 33(10):6892-6901. PubMed ID: 37133518
[TBL] [Abstract][Full Text] [Related]
39. Diffusion-weighted MRI of the prostate at 3.0 T: comparison of endorectal coil (ERC) MRI and phased-array coil (PAC) MRI-The impact of SNR on ADC measurement.
Mazaheri Y; Vargas HA; Nyman G; Shukla-Dave A; Akin O; Hricak H
Eur J Radiol; 2013 Oct; 82(10):e515-20. PubMed ID: 23810189
[TBL] [Abstract][Full Text] [Related]
40. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
